Comparative efficacy and safety of low-intensity warfarin therapy in preventing unprovoked recurrent venous thromboembolism: A systematic review and meta-analysis-Reference-Cited by-同舟云学术

Comparative efficacy and safety of low-intensity warfarin therapy in preventing unprovoked recurrent venous thromboembolism: A systematic review and meta-analysis

Published:2018-06-13 Issue:7 Volume:12 Page:2170-2177
ISSN:1752-6981
Container-title:The Clinical Respiratory Journal
language:en
Short-container-title:Clin Respir J

Author:

Jiang Rong¹^ORCID,Shi Yu²,Zhang Rui¹,Pudasain Bigyan¹,Wang Lan¹,Zhao Qin-Hua¹,Yuan Ping¹,Guo Jian³,Zhu Chang-Tai⁴,Liu Jin-Ming¹

Affiliation:

1. Department of Cardio-Pulmonary Circulation; Shanghai Pulmonary Hospital, Tongji University School of Medicine; Shanghai 200433 China

2. Department of Cardiology; Yantai Yu-Huangding Hospital, Medical College of Qingdao University; Yantai 264000 China

3. Department of Pulmonary Function Test; Shanghai Pulmonary Hospital, Tongji University School of Medicine; Shanghai 200433 China

4. Department of Transfusion Medicine; Shanghai Jiao Tong University Affiliated Sixth People's Hospital, No. 600 Yishan Rd; Shanghai 200233 China

Funder

Shanghai Municipal Health and Family Planning Commission

Shanghai Pulmonary Hospital

Publisher

Wiley

Subject

Genetics (clinical),Pulmonary and Respiratory Medicine,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/crj.12795/fullpdf

Reference30 articles.

1. 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism;Konstantinides;Eur Heart J.,2014

2. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines;Kearon;Chest.,2012

3. A comparison of six weeks with six months of oral anticoagulant therapy after a first episode of venous thromboembolism. Duration of Anticoagulation Trial Study Group;Schulman;N Engl J Med.,1995

4. The duration of oral anticoagulant therapy after a second episode of venous thromboembolism. The Duration of Anticoagulation Trial Study Group. The;Schulman;N Engl J Med.,1997

5. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis. Warfarin Optimal Duration Italian Trial Investigators;Agnelli;N Engl J Med.,2001

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Challenging clinical scenarios for therapeutic anticoagulation: A practical approach;Thrombosis Research;2022-10

2. Reversal of anticoagulation in neurosurgical and neurocritical care settings;Essentials of Evidence-Based Practice of Neuroanesthesia and Neurocritical Care;2022